Hepatocellular adenoma (HCA) is an uncommon benign hepatic tumor, and the use of oral contraceptives is known to contribute to the development of HCA. Recently, a genotype and phenotype classification system for HCA was suggested, and malignant transformation to hepatocellular carcinoma (HCC) was shown to be strongly associated with activating mutations in β-catenin. Here, we report three cases of HCA in Korean patients: 7-cm, inflammatory and β-cateninactivated HCA with HCC transformation in a 46-year-old man; 13-cm, β-catenin-activated HCA with cytological atypia in a 23-year-old woman; and 10-cm, pigmented, inflammatory and β-catenin-activated HCA in a 36-year-old man. All cases exhibited the nuclear expression of β-catenin and diffuse cytoplasmic expression of glutamine synthetase upon immunohistochemical staining. All tumors were completely resected, and the patients were followed for 3 to 6 years with no evidence of local recurrence or metastasis. (Gut Liver 2014;8:452-458) 
INTRODUCTION
Hepatocellular adenoma (HCA) is an uncommon benign liver tumor, constituting 2% of all liver neoplasms. 1 It is known to occur mainly in women with a history of oral contraceptive use. 2 Although a rare occurrence, hepatocellular carcinoma (HCC) can arise from HCA. 3 Recent studies have revealed that β-catenin mutation is the leading cause for the malignant transformation of HCA to HCC. [4] [5] [6] Here we report three cases of
Case 1
A 46-year-old man showed a hepatic mass found during a routine check-up. His past history was unremarkable and he had no history of alcohol or drug abuse. Laboratory findings were all within normal ranges, including aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, lactate dehydrogenase, total bilirubin, and total protein. Hepatitis B surface antigen and antihepatitis C virus antibody were negative, but anti-HBs antibody was positive. Serum levels of α-fetoprotein and protein-induced by vitamin K absence or antagonist II were normal.
Liver dynamic computed tomography (CT) showed an arterial enhancing 6-cm sized lesion without washout in portal and delayed phase. Gadobenate dimeglumine (Gd-BOPTA) enhanced magnetic resonance imaging (MRI) showed slight hyposignal intensity in T1-weighted image, and arterial enhancement without washout on portal phase. In 3-hour delayed hepatobiliary phase, the lesion was hypointense. In T2-weighted image, the lesion was diffusely hyperintense with poorly defined hyperintense foci. The findings were characteristic of HCA. However, there was a focal washout area within the enhancing mass, which may suggest HCC (Fig. 1A-E) .
Right lobectomy was performed and the specimen revealed a multilobular mass measuring 7×5 cm with a nodule-in-nodule pattern (Fig. 1F) . Microscopically, the mass showed a welldefined border with an expanding growth pattern ( Fig. 2A) . The outer nodules, the major part of the tumor, were composed of hepatocyte-like cells with mild nuclear atypia (Fig. 2B) . The tumor cells were arranged in trabecular cords of one-or twocell thickness. There were several abnormal vessels with mononuclear infiltrates (Fig. 2C) . In contrast, the inner nodule showed an acinar pattern and prominent cellular atypia with stromal invasion (Fig. 2D) . The tumor cells of the outer and inner nodules showed positivity for serum amyloid protein A (SAA) (Fig. 2E) , diffuse strong cytoplasmic expression of glutamine synthetase (GS) (Fig. 2F ) and nuclear expression of β-catenin (Fig. 2G) . In contrast, the expression of heat shock protein 70 (HSP-70) was found in only the inner nodule (Fig. 2H) . The nonneoplastic liver showed mild macrovesicular steatosis. Taken together, the inner nodule was discerned to be a malignant transformation of HCA. The patient has been followed up regularly for 6 years with no evidence of metastasis or recurrence after operation.
Case 2
A 23-year-old woman presented with a huge hepatic mass. Her past medical history was unremarkable and she had no history of oral contraceptive use. The laboratory findings were normal. Liver dynamic CT showed an approximately 13-cm mass replacing almost entire right hepatic lobe. The mass showed arterial enhancement and washout on portal and delay phase. On MRI, the mass showed slight low signal intensity in T1-weighted image and gross fat component in dual-echo T1-weighted image. On T2-weighted image, the lesion showed slight high signal intensity, and T2 hyperintense, delayed enhancing central scar. With gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) injection, the mass showed arterial enhancement, subsequent slight washout, and hypointensity on hepatobiliary phase (Fig. 3) .
Right lobectomy was performed. Macroscopic examina- In-phase (IP) (A) and opposed-phase (OP) (B) T1-weighted, gradient echo images show an isointense lesion on IP images, whereas a hyperintense mass (black arrow) appears on the OP image due to decreased signal in the surrounding liver (white arrows). A T2-weighted image (T2 WI) (C) shows a slightly hyperintense mass. An axial, gadobenate dimeglumine-enhanced, T1-weighted, gradient echo image in the arterial phase (D) shows a homogeneous enhancement of the mass (arrow). An axial, gradient echo image in the delayed phase (E) shows no washout of the contrast. These features are consistent with hepatocellular adenoma; however, a washout area within the enhanced mass is suspicious for hepatocellular carcinoma (arrow). (F) Gross features of case 1. The resected specimen demonstrates a well-defined and multilobular mass measuring 7×5 cm, and a yellowish nodule is noted at the center (arrow).
tion revealed a well-delimited tumor measuring 13 cm in size. Microscopically, the tumor was composed of hepatocyte-like cells with abundant and eosinophilic granular cytoplasm. Most tumor cells showed a bland-looking appearance, but focal areas exhibited an acinar pattern and nuclear pleomorphism (Fig. 4A ).
Immunohistochemistry revealed focal nuclear expression of β-catenin (Fig. 4B ), diffuse expression of GS (Fig. 4C ) and focal expression of HSP-70 (Fig. 4D) . The nonneoplastic liver showed mild nonspecific reactive hepatitis. Taken together, the findings were consistent with β-catenin activated HCA with cytological atypia. The patient has been followed up for 3 years with no evidence of recurrence or metastasis of the tumor.
Case 3
A 36-year-old man presented with an incidental hepatic mass. His past history was unremarkable and laboratory findings were normal. Gd-EOB-DTPA enhanced MRI showed a mass at left lateral segment. The mass was slightly hyperintense in T2-weighted image with several poorly defined bright foci, and isointense in T1-weighted image, and arterial enhancement and slight washout on late dynamic phase. The mass was hypointense at hepatobiliary phase image. On MRI, no gross fat or hemorrhage was noted in the tumor (Fig. 5A-E) .
Left lobectomy was performed. Macroscopically, the specimen comprised a huge mass, measuring 10 cm in size, with a cut surface showing a dark-green color and focal areas of congestion (Fig. 5F) . Microscopically, the nuclei of tumor cells were slightly larger than those of the nontumor hepatocytes. Moderate mononuclear inflammatory cell infiltrates were found around abnormally shaped blood vessels. In the cytoplasm of the tumor cells, dark-brown colored granular pigment was observed ( Fig. 6A) , which was positive with Fontana-Masson stain (Fig. 6B) , mimicking Dubin-Johnson-like pigment. Additionally, diffuse immunoexpression of SAA (Fig. 6C) and C-reactive protein (CRP) (Fig. 6D ) was noted. GS was diffusely positive (Fig.  6E ) and there was rare nuclear expression of β-catenin (Fig. 6F) . The nonneoplastic liver showed mild nonspecific reactive hepatitis. These features suggested the diagnosis of inflammatory and β-catenin-activated HCA. The patient has been followed up for a period of 3 years with no evidence of local recurrence or metastasis after operation.
DISCUSSION
HCA is a rare benign tumor that usually develops in noncirrhotic liver, and is more frequently found in women than in men. 7 The use of oral contraceptives is widely accepted as contributing to the development of HCA, and the natural history of HCAs is closely correlated with the dose and duration of oral contraceptive used. 2 An increased risk of HCA is also associated with anabolic androgens, metabolic disorders, and vascular diseases. 8, 9 Recent reports from Eastern countries, however, suggest that HCAs exhibit significant epidemiological differences between Eastern and Western patients. In Eastern countries, HCAs have been reported mainly in males, and the degree of association with the use of oral contraceptives is much lower than that in Western populations. A review of 206 Asian patients reported a male preponderance of 59.7% (123/206) and only 13.2% (11/83) of female patients had a history of using oral contraceptives. 10 Based on genotype-phenotype features, HCAs can be subcategorized as follows: 1) HCA with mutations in hepatocyte nuclear factor 1α (HNF1α); 2) HCA with mutations in the β-catenin gene; 3) HCA with inflammatory features; and 4) HCA, not otherwise specified. 4, 6 Mutations in HNF1α, observed in approximately 35% of cases of HCA, are considered the least likely to involve malignant transformation. The presence of activating mutation in β-catenin, however, has been identified in about 10% of all HCA cases, and is highly correlated with malignant transformation. 4, 5 Inflammatory HCAs are characterized as displaying mononuclear infiltrates and immunohistochemically positivity for SAA and CRP. About one tenth of these HCAs have been reported to comprise mutations in the β-catenin gene. 6 All cases of the present report were considered to be indicative of β-catenin activated HCA; the first and the third cases were demonstrative of HCA with inflammatory features. The first case showed features of malignant transformation with a nodule-in-nodule pattern and stromal invasion. In the others, worrisome features suggesting HCC were present, but there was no definite evidence of malignant transformation. All patients have shown no disease recurrence or metastasis for at least 3 years after treatment. Distinguishing HCA from well-differentiated HCC is very important for the treatment of the patients, but it is difficult and sometimes impossible to attain, even in resected specimens. Histological features suggestive of HCC include liver cell plates of more than three cells thick, increased cellularity with high nuclear/cytoplasm ratio, and stromal invasion of tumor cells. 11 Immunohistochemically, application of identification of glypican-3 expression is recommended to detect well-differentiated HCC. However, its usefulness is limited because it has been reported to be negative in one third of HCCs. 12 Therefore, it is more helpful to apply a combination of HCC markers including glypican-3, HSP-70, and GS to distinguish well differentiated HCC from HCA. 13 Identification of β-catenin gene mutation is also important as β-catenin activation in HCA is associated with risk of malignant potential, and it shows an aberrant nuclear and cytoplasmic expression of β-catenin and a diffuse, strong expression of GS. 5 Therefore, combined application of identification of β-catenin and GS expression may be more effective in distinguishing β-catenin activated HCA from other subtypes of HCA. Interestingly, Dubin-Johnson-like pigment was observed in the third case of the present study. The pigment showed larger and darker granules than lipofuscin, and was positive for Fontana-Masson stain. Recent study has indicated that DubinJohnson pigment is actually derived from lipofuscin, atypical bile pigments, or porphyrins, and may arise as the result of a defect in biliary excretion. 14 In the literature, among seven series, eight cases of pigmented HCA have been reported, and one of those was diagnosed as HCC.
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